{"title":"Post-Bariatric Hypoglycemia After Gastric Bypass: Clinical Characteristics, Risk Factors, and Future Directions-A Response to Grover et al.","authors":"Chi-Wei Ye, Lien-Chung Wei","doi":"10.1111/cen.15229","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Post-bariatric hypoglycemia (PBH) after Roux-en-Y gastric bypass (RYGB) is a complex complication, often characterized by potentially severe hypoglycemic episodes and reduced hypoglycemia awareness. Recent findings suggest that autonomic dysfunction, preoperative hypoglycemia symptoms, and early dumping syndrome may each contribute to PBH risk.</p><p><strong>Objective: </strong>To discuss critical insights from the recent study by Grover et al. regarding the clinical characteristics, prevalence, and possible contributing factors of PBH, and to propose avenues for future research, including standardized preoperative screening and targeted dietary interventions.</p><p><strong>Discussion: </strong>Current evidence underscores a high prevalence of severe (level 3) hypoglycemia episodes among PBH patients, with notable rates of autonomic dysfunction and neuropathy. Dietary strategies (e.g., fermented wheat supplements) hold promise for mitigating PBH-related complications. Emerging data further highlight the significance of preoperative hypoglycemia symptoms and dumping syndrome as early predictors of PBH risk, emphasizing the need for improved risk stratification.</p><p><strong>Conclusion: </strong>Comprehensive preoperative screening, investigation of autonomic dysfunction in glucose metabolism, and individualized dietary or pharmacological interventions may optimize PBH management. These strategies could refine patient selection, reduce hypoglycemia incidence, and improve long-term outcomes for individuals undergoing RYGB.</p>","PeriodicalId":10346,"journal":{"name":"Clinical Endocrinology","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Endocrinology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/cen.15229","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Post-bariatric hypoglycemia (PBH) after Roux-en-Y gastric bypass (RYGB) is a complex complication, often characterized by potentially severe hypoglycemic episodes and reduced hypoglycemia awareness. Recent findings suggest that autonomic dysfunction, preoperative hypoglycemia symptoms, and early dumping syndrome may each contribute to PBH risk.
Objective: To discuss critical insights from the recent study by Grover et al. regarding the clinical characteristics, prevalence, and possible contributing factors of PBH, and to propose avenues for future research, including standardized preoperative screening and targeted dietary interventions.
Discussion: Current evidence underscores a high prevalence of severe (level 3) hypoglycemia episodes among PBH patients, with notable rates of autonomic dysfunction and neuropathy. Dietary strategies (e.g., fermented wheat supplements) hold promise for mitigating PBH-related complications. Emerging data further highlight the significance of preoperative hypoglycemia symptoms and dumping syndrome as early predictors of PBH risk, emphasizing the need for improved risk stratification.
Conclusion: Comprehensive preoperative screening, investigation of autonomic dysfunction in glucose metabolism, and individualized dietary or pharmacological interventions may optimize PBH management. These strategies could refine patient selection, reduce hypoglycemia incidence, and improve long-term outcomes for individuals undergoing RYGB.
期刊介绍:
Clinical Endocrinology publishes papers and reviews which focus on the clinical aspects of endocrinology, including the clinical application of molecular endocrinology. It does not publish papers relating directly to diabetes care and clinical management. It features reviews, original papers, commentaries, correspondence and Clinical Questions. Clinical Endocrinology is essential reading not only for those engaged in endocrinological research but also for those involved primarily in clinical practice.